Aberdeen Group
CTMX icon

Aberdeen Group’s CytomX Therapeutics CTMX Stock Holding History

Aberdeen Group’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-13,403
Closed -$381K – 902
2018
Q1 		$381K Buy
+13,403
New +$381K ﹤0.01% 778